Gene Therapy In The Post-Gelsinger Era
As gene therapy research races to a first cure of a genetic-based disease, the research community has struggled with the aftermath of the well-publicized death of Jesse Gelsinger from complications of an experimental treatment. In a wrongful death lawsuit against the University of Pennsylvania and its researchers, Jesse Gelsinger’s family alleged violations of federal regulations and research ethics. This article reviews gene therapy research, examines the role of the key players in this tragedy, and provides suggestions for preventing future misfortunes. © 2002 Lippincott Williams & Wilkins, Inc.
JONA's Healthcare Law, Ethics, and Regulation
Number of Pages
Source API URL
Smith, Lynn and Byers, Jacqueline Fowler, "Gene Therapy In The Post-Gelsinger Era" (2002). Scopus Export 2000s. 2792.